A 3-Tier AI Model for COVID-19 Triage Using Pharyngeal Images: Algorithm Development and Validation

SARS-CoV-2 remains a common cause of acute respiratory illness; however, symptom-based triage poorly discriminates it from other febrile conditions. A recently developed artificial intelligence (AI)-powered pharyngeal camera acquires pharyngeal images and clinical data to assist in influenza diagnosis; leveraging this workflow, we evaluated an adjunct AI algorithm (COVID-19-AI) that reports high, medium, or low suspicion to guide whether SARS-CoV-2 testing should subsequently be performed.

This study aimed to report diagnostic accuracy outcomes and clinical utility of the COVID-19-AI as a triage support tool.

We conducted a performance evaluation using a prospectively collected multicenter dataset from 26 Japanese institutions between December 2023 and March 2024. Patients with suspected influenza or COVID-19 were eligible. The COVID-19-AI algorithm, a stacked ensemble of a Swin Transformer and boosting models, was developed using pharyngeal images combined with routine clinical variables from 2133 patients, and it produced a 3-tier output. Classification thresholds were predefined to optimize clinical rule-out and rule-in utilities. Diagnostic performance was assessed in 696 independent patients against centralized reverse transcription polymerase chain reaction-confirmed SARS-CoV-2 infection under 2 prespecified operating criteria: inclusive (high or medium=positive and low=negative) and strict (high=positive and medium or low=negative). A subanalysis stratified accuracy by time from symptom onset (12-hour bins to 72 hours).

Among 696 analyzed participants (all Asian), 247 (35.5%) had reverse transcription polymerase chain reaction-confirmed SARS-CoV-2 infection. The COVID-19-AI categorized 12.4% (n=86), 72.8% (n=507), and 14.8% (n=103) patients as high, medium, and low suspicion, respectively. Under the inclusive criteria, sensitivity of COVID-19-AI was 93.9% (95% CI 90.4%-96.4%), specificity was 19.6% (95% CI 16.1%-23.5%), and negative predictive value was 85.4% (95% CI 77.6%-91.3%). Under the strict criteria, sensitivity was 24.7% (95% CI 19.6%-30.4%), specificity was 94.4% (95% CI 92.0%-96.3%), and positive predictive value was 70.9% (95% CI 60.7%-79.8%). Across 12-hour onset strata, sensitivity under the inclusive criteria remained ≥92.0% and specificity under the strict criteria remained ≥83.3%; no pronounced temporal trend was observed. Additionally, an integrated model using both pharyngeal images and clinical variables (area under the receiver operating characteristic curve [AUROC] 0.78) outperformed models using only clinical variables (AUROC 0.75) or images alone (AUROC 0.71); feature importance analysis further confirmed that pharyngeal image information was the most influential individual predictor, providing greater predictive value than any single clinical variable.

Embedded within AI-powered pharyngeal camera workflows, a 3-tier AI suspicion output enables complementary operating behaviors-high sensitivity to rule out COVID-19 (inclusive criteria) and high specificity to support immediate infection control measures (strict criteria), although these criteria involve inherent trade-offs with low specificity and low sensitivity, respectively. Performance stability across onset times suggests robustness to symptom chronology, offering a standardized tool for clinical triage.